AstraZeneca and Innate Pharma enter into partnership for the development of CD39 mAbs

AstraZeneca and Innate Pharma enter into partnership for the development of CD39 mAbs
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more